BACKGROUND: The transcription factor T-bet mediates IFN-gamma production by T(H)1 cells and suppresses T(H)2 cytokine production when ectopically expressed in polarized murine T(H)2 cells. Thus T-bet-mediated inhibition of T(H)2 cytokine production might be beneficial for the treatment of allergic diseases like asthma or atopic dermatitis. OBJECTIVE: We sought to investigate the effects of ectopic T-bet expression in highly polarized human T(H)2 cells obtained from skin biopsy specimens of patients with atopic dermatitis. METHODS: The cytokine production of T(H)2 cells retrovirally transfected with a vector expressing human T-bet was determined by means of intracellular FACS staining and ELISA. The effects of T-bet transfection were analyzed at the mRNA level by means of real-time PCR and DNA microarrays and confirmed by using functional chemokine response assays. RESULTS: Transfection of T-bet into T(H)2 cells induced high levels of IFN-gamma and suppressed IL-5, but IL-2 and IL-4 production remained unchanged. T-bet transfection also induced IL-12Rbeta2 and CXCR3 expression on human T(H)2 cells, whereas the IL-18 receptor was only induced as a consequence of T-bet-mediated increased responsiveness to IL-12. Furthermore, sustained T-bet expression in human T(H)2 cells induced IL-2 production and decreased the secretion of IL-4. In addition, the chemokine receptor repertoire of these cells was changed toward a T(H)1-like profile. CONCLUSION: The combined switch in cytokine pattern and migratory potential of highly polarized human T(H)2 cells mediated by T-bet might provide an additional advantage for the treatment of allergic diseases.
BACKGROUND: The transcription factor T-bet mediates IFN-gamma production by T(H)1 cells and suppresses T(H)2 cytokine production when ectopically expressed in polarized murine T(H)2 cells. Thus T-bet-mediated inhibition of T(H)2 cytokine production might be beneficial for the treatment of allergic diseases like asthma or atopic dermatitis. OBJECTIVE: We sought to investigate the effects of ectopic T-bet expression in highly polarized human T(H)2 cells obtained from skin biopsy specimens of patients with atopic dermatitis. METHODS: The cytokine production of T(H)2 cells retrovirally transfected with a vector expressing humanT-bet was determined by means of intracellular FACS staining and ELISA. The effects of T-bet transfection were analyzed at the mRNA level by means of real-time PCR and DNA microarrays and confirmed by using functional chemokine response assays. RESULTS: Transfection of T-bet into T(H)2 cells induced high levels of IFN-gamma and suppressed IL-5, but IL-2 and IL-4 production remained unchanged. T-bet transfection also induced IL-12Rbeta2 and CXCR3 expression on human T(H)2 cells, whereas the IL-18 receptor was only induced as a consequence of T-bet-mediated increased responsiveness to IL-12. Furthermore, sustained T-bet expression in human T(H)2 cells induced IL-2 production and decreased the secretion of IL-4. In addition, the chemokine receptor repertoire of these cells was changed toward a T(H)1-like profile. CONCLUSION: The combined switch in cytokine pattern and migratory potential of highly polarized human T(H)2 cells mediated by T-bet might provide an additional advantage for the treatment of allergic diseases.
Authors: Jennifer L Matsuda; Qianjun Zhang; Rachel Ndonye; Stewart K Richardson; Amy R Howell; Laurent Gapin Journal: Blood Date: 2005-12-15 Impact factor: 22.113
Authors: Jingsong Wang; John W Fathman; Geanncarlo Lugo-Villarino; Lucila Scimone; Ulrich von Andrian; David M Dorfman; Laurie H Glimcher Journal: J Clin Invest Date: 2006-01-12 Impact factor: 14.808
Authors: Melba Muñoz; Ahmed N Hegazy; Tobias M Brunner; Vivien Holecska; Roman M Marek; Anja Fröhlich; Max Löhning Journal: Proc Natl Acad Sci U S A Date: 2021-02-09 Impact factor: 11.205
Authors: Benjamin A Raby; Eun-Sook Hwang; Kristel Van Steen; Kelan Tantisira; Stanford Peng; Augusto Litonjua; Ross Lazarus; Cosmas Giallourakis; John D Rioux; David Sparrow; Edwin K Silverman; Laurie H Glimcher; Scott T Weiss Journal: Am J Respir Crit Care Med Date: 2005-09-22 Impact factor: 21.405
Authors: G Frisullo; V Nociti; R Iorio; A K Patanella; D Plantone; A Bianco; A Marti; G Cammarota; P A Tonali; A P Batocchi Journal: Clin Exp Immunol Date: 2009-10 Impact factor: 4.330
Authors: Michael W Lipscomb; Lu Chen; Jennifer L Taylor; Christina Goldbach; Simon C Watkins; Pawel Kalinski; Lisa H Butterfield; Amy K Wesa; Walter J Storkus Journal: J Immunol Date: 2009-11-13 Impact factor: 5.422